RESILIENCE: BIOLOGICAL BASIS AND CLINICAL SIGNIFICANCE - A PERSPECTIVE REPORT FROM THE INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH (ICFSR) TASK FORCE
M. Cesari, D. Azzolino, N.K. LeBrasseur, H. Whitson, D. Rooks, S. Sourdet, D. Angioni, R.A. Fielding, B. Vellas, Y. Rolland
J Frailty Aging 2022;11(4)342-347
scientific community in geriatrics and gerontology. Older adults show extremely heterogeneous (and often unpredictable) responses to stressors. Such heterogeneity can (at least partly) be explained by differences in resilience (i.e., the capacity of the organism to cope with stressors). The International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force met in Boston (MA,USA) on April 20, 2022 to discuss the biological and clinical significance of resilience in older adults. The identification of persons with low resilience and the prompt intervention in this at-risk population may be critical to develop and implement preventive strategies against adverse events. Unfortunately, to date, it is still challenging to capture resilience, especially due to its dynamic nature encompassing biological, clinical, subjective, and socioeconomic factors. Opportunities to dynamically measure resilience were discussed during the ICFSR Task Force meeting, emphasizing potential biomarkers and areas of intervention. This article reports the results of the meeting and may serve to support future actions in the field.
M. Cesari ; D. Azzolino ; N.K. LeBrasseur ; H. Whitson ; D. Rooks ; S. Sourdet ; D. Angioni ; R.A. Fielding ; B. Vellas ; Y. Rolland ; (2022): Resilience: Biological Basis and Clinical Significance - A Perspective Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force. The Journal of Frailty and Aging (JFA). http://dx.doi.org/10.14283/jfa.2022.62